×
To start your customized experience click the start button
Customize
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2017
CURE Communications Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Sponsored Content: Dr. Shannon Westin on PARP Inhibition for Ovarian Cancer

PUBLISHED: JULY 20, 2017
Dr. Westin is a clinical investigator with a focus on developmental therapeutics and the use of biomarkers to predict response and recurrence in gynecologic cancers. Her background in public health, with a focus on clinical investigation and epidemiology, has provided her with a clear understanding of the study design and validation techniques which are essential to the study of these topics. She is the principal investigator of several novel treatment trials for endometrial cancer as well as a Phase I trial of agents relevant to ovarian cancer.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

In Treatment

Maintenance/Hormone Treatment

Out of Treatment

Caregiver

Healthcare Professional

Not Applicable